Gain insights from rare disease experts on addressing unique challenges in rare disease drug development.
Bringing effective therapeutics to market to address rare conditions is a complex undertaking. In recent years the study of rare diseases has seen increased support and industry interest, however, drug developers continue to face unique challenges brought about by small, heterogeneous patient populations, intricate trial designs and the need for clinical development expertise in diseases with low prevalence. Embracing these challenges can create opportunities for growth and innovation. Enhance your R&D by reading this eBook, which is based on the findings of an industry survey.
Offered Free by: PPD
See All Resources from: PPD
